|
|
|
NAFLD
https://pubmed.ncbi.nlm.nih.gov/35013082/ NAFLD
AIDS. 2022 Jan 10.
doi: 10.1097/QAD.0000000000003170. Online ahead of print.
Prevalence of non-alcoholic fatty liver disease using non-invasive techniques among children, adolescents, and youths living with HIV
Itzíar Carrasco 1, Antonio Olveira, Ángel Lancharro, Luis Escosa, María José Mellado, Carmen Busca, María Luisa Montes, Cristina Diez, Sonia Alcolea, María Luisa Navarro, Talía Sainz
Abstract
https://pubmed.ncbi.nlm.nih.gov/38771552/ NAFLD
Review
World J Pediatr. 2024 May 21.
doi: 10.1007/s12519-024-00814-1.Online ahead of print.
Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysis
Eun Joo Lee 1, Miyoung Choi 2, Sang Bong Ahn 3, Jeong-Ju Yoo 4, Seong Hee Kang 5, Yuri Cho 6, Do Seon Song 7, Hong Koh 1, Dae Won Jeon 8, Hye Won Lee 9
Affiliations expand
PMID: 38771552
DOI: 10.1007/s12519-024-00814-1
Abstract
Background: As childhood obesity escalates worldwide, the prevalence of nonalcoholic fatty liver disease (NAFLD) in pediatric and adolescent populations is also increasing. However, systematic studies and meta-analyses evaluating the prevalence of pediatric NAFLD remain limited.
https://pubmed.ncbi.nlm.nih.gov/38771552/ NAFLD
Review
World J Pediatr. 2024 May 21.
doi: 10.1007/s12519-024-00814-1.Online ahead of print.
Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysis
Eun Joo Lee 1, Miyoung Choi 2, Sang Bong Ahn 3, Jeong-Ju Yoo 4, Seong Hee Kang 5, Yuri Cho 6, Do Seon Song 7, Hong Koh 1, Dae Won Jeon 8, Hye Won Lee 9
Affiliations expand
PMID: 38771552
DOI: 10.1007/s12519-024-00814-1
Abstract
Background: As childhood obesity escalates worldwide, the prevalence of nonalcoholic fatty liver disease (NAFLD) in pediatric and adolescent populations is also increasing. However, systematic studies and meta-analyses evaluating the prevalence of pediatric NAFLD remain limited.
https://pubmed.ncbi.nlm.nih.gov/36849108/ NAFLD
Horm Metab Res. 2023 Feb 27.
doi: 10.1055/a-2043-1044. Online ahead of print.
Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children
Jianwei Zhang 1, Jieqiong Guan 1, Xiaoli Tang 1, Jinliang Xu 1
Abstract
https://pubmed.ncbi.nlm.nih.gov/35133671/ NAFLD
Hepatology. 2022 Feb 8.
doi: 10.1002/hep.32403. Online ahead of print.
Randomized Placebo-Controlled Trial of Losartan for Pediatric Nonalcoholic Fatty Liver Disease
Miriam B Vos 1, Mark L Van Natta 2, Niviann M Blondet 3, Srinivasan Dasarathy 4, Mark Fishbein 5, Paula Hertel 6, Ajay K Jain 7, Saul J Karpen 1, Joel E Lavine 8, Saeed Mohammad 5, Laura A Miriel 2, Jean P Molleston 9, Marialena Mouzaki 10, Arun Sanyal 11, Emily P Sharkey 2, Jeffrey B Schwimmer 12, James Tonascia 2, Laura A Wilson 2, Stavra A Xanthakos 10, NASH Clinical Research Network
Abstract
https://pubmed.ncbi.nlm.nih.gov/34723254/ NAFLD
JPGN Rep. 2021 May;2(2):e077.
doi: 10.1097/PG9.0000000000000077.
Relationship of Vitamin D Deficiency and Fatty Liver in Children as Defined by Multiple Imaging and Histologic Endpoints
Bryan Rudolph 1, Tyler Selig 2, Yingjie Li 1, Nadia Ovchinsky 1, Debora Kogan-Liberman 1, Mark C Liszewski 3, Terry Levin 3, Michelle Ewart 4, Qiang Liu 4, Shankar Viswanathan 5, Juan Lin 5, Xiaonan Xue 5, Robert D Burk 5, Howard D Strickler 5
Abstract
https://pubmed.ncbi.nlm.nih.gov/35064452/ NAFLD
Indian J Gastroenterol. 2022 Jan 21.
doi: 10.1007/s12664-021-01198-0. Online ahead of print.
Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors
Srinivasan Thiagarajan 1, Sadhanandham Shrinuvasan 2, Thirunavukkarasu Arun Babu 3
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized in obese and overweight children. NAFLD is the commonest cause of chronic liver disease in these children. We undertook a study to assess the prevalence of NAFLD and to identify the associated anthropometric and metabolic risk factors.
http://www.ncbi.nlm.nih.gov/pubmed/26513612
Cengiz M, Ozenirler S, Kocabiyik M. Serum β-trophin level as a new marker for noninvasive assessment of nonalcoholic fatty liver disease and liver fibrosis. Eur J Gastroenterol Hepatol. 2016 Jan; 28(1):57-63.
Abstract
OBJECTIVE:
Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease and evaluation of fibrosis is important. We aimed to investigate the utility of serum β-trophin in NAFLD and its ability to predict liver fibrosis.
PATIENTS AND METHODS:
https://pubmed.ncbi.nlm.nih.gov/38114813/ NAFLD
Int J Obes (Lond). 2023 Dec 20.
doi: 10.1038/s41366-023-01439-6. Online ahead of print.
Sex-specific differences in ectopic fat and metabolic characteristics of paediatric nonalcoholic fatty liver disease
Eun Hye Lee 1, Ji Young Kim 2, Hye Ran Yang 3 4
Abstract
Background/objectives: Sex-specific differences in obesity-related metabolic characteristics of non-alcoholic fatty liver disease (NAFLD) have rarely been explored, particularly in children with biopsy-verified NAFLD. The influence of sex hormones on ectopic fat disposition may cause inter-sex differences in various metabolic factors. This study aimed to assess the sex-based differences in ectopic fat and metabolic characteristics in children with NAFLD.
https://pubmed.ncbi.nlm.nih.gov/38025490/ NAFLD
Significance of Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio in Children with Non-Alcoholic Fatty Liver Disease
Hyun Jin Kim 1
Abstract
Purpose: Nonalcoholic fatty liver disease (NAFLD) is associated with obesity and metabolic syndrome. This study evaluated the significance of markers such as the triglyceride-to-high-density lipoprotein cholesterol (TG/HDL-C) ratio and TG-glucose (TyG) indices in a group of patients with NAFLD.
Methods: We retrospectively analyzed the data of patients aged 5-18 years diagnosed with NAFLD between January 2014 and January 2021.
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
